Trending...
- The Anderson Periodontal Wellness Office Now Uses Zirconia Dental Implants to Restore Smiles!
- Dental Tourism is on the Rise and This Dental Hygienist is Providing the Consultations
- New Book Launches to Bestseller Status--Answers the Question "Why Is It So Hard to Find Quality Workers?"
QView's AI-QVCAD, combined with GEHC's ABUS breast ultrasound system, potentially accelerates the acceptance of 3D breast ultrasound as supplemental screening for women with dense breast tissue.
LOS ALTOS, Calif. - PRDelivery -- QView, Inc., a medical technology leader providing artificial intelligence systems for breast cancer detection, and GEHC have signed a distribution agreement where QView Medical's AI-QVCAD software system will be added to GEHC's portfolio of breast imaging AI solutions for the detection and diagnosis of breast cancer.
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on PR Delivery
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on PR Delivery
--
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on PR Delivery
- Hookahville 56 Lineup Announcement
- Climate Institute Signs Agreement with Swiss-Based 2000-Watt Smart Cities Association to Promote New Climate Change Programs in the United States
- Wildflower Bee Farm publishes new book "What Grandpa Learned from His Honeybees"
- Calvetta Phair, CEO of America's Workforce Solution, LLC, Charitable Partner - 'The On It Foundation' Qualify to Distribute Google Career Certificates
- Veterans for Trump endorsement of MS Senator Chris McDaniel for Lieutenant Governor
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on PR Delivery
- DonnaInk Publications signs Author, SAG Agent Theresa Lynn Zaino's, "Born to Compete"
- Texas Automotive Lift & Equipment Distributor chooses Employees Ownership
- Louisville Riverport Authority Applies To Include South Central Kentucky In Foreign Trade Zone #29 Service Area
- IntellaTriage Hires New Director of Clinical Operations
- Metro Commercial brokers deal for BJ's Wholesale Club in West Palm Beach, FL
--
- Boyd, et al, NEJM Jan 2007
- Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women with Dense Breast Tissue (Yulei Jiang). Read More: https://www.ajronline.org/doi/10.2214/AJR.18.19516
- Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Read More: https://pubs.rsna.org/doi/10.1148/radiol.2019181816
Source: Qview Medical, Inc.
0 Comments
Latest on PR Delivery
- Yida Gao and Shima Capital Celebrate Portfolio Company's Successful NFT Sellout
- "Murdaugh Murders Podcast" Launches Spinoff "Cup of Justice" and Skyrockets to Apple's #1 Podcast
- CPAC 2023 Congressional Candidate Forum Meet and Greet March 2nd at the historic University Club in DC
- IoT Observatory to host Plenary Session at 2023 InsurTech Hartford Symposium
- Eliza Neals "Candy Store" new spring single out February 14th Valentines Day 2023!
- The Case For Bonds As Part Of A Portfolio
- Cardinal Analytics Launches on the Bloomberg App Portal
- 24th Annual Super Bowl Soulful Celebration Returns On Feb. 8 With Patti LaBelle, Israel Houghton & The Players Choir, Honoring NFL QB Jalen Hurts
- Orbex to Exhibit as Diamond Sponsor at the Fintech & Crypto Summit Bahrain, 2023
- Photography Book Makes Black History Month Fun
- Historic Groundbreaking Documentary About Women Marathoners Released for Black History Month
- 3DMyRental Launches Professional 3D Floor Plan Services for Airbnb Hosts: A Game-Changing Solution for Property Rentals
- Best Online End-Of-Season Clearance Sale at Sunber Hair: $56 For A Lace Wig
- UNice Hair Partners With Awin Affiliate Marketing Network To Accelerate Business Growth
- My Lineage Proudly Supports Knights of Heroes
- The Town Of Sun Village California Makes History As The First Black Tribal Township In North America
- Flawless Torres ft. Diamonique x Sean Kingston Releases "Lets Go" on 1/27/23!
- We're In Paris Is Sidow Sobrino's Newly Released Song and Video
- Abusive Russian to face Pro Wrestling Legend!
- Jim Wilson, Top Notch Realtor in waterfront and beach properties in Redington, Redington Shores, and North Redington Beach, FLorida